Insider Transactions Reported by 16 Insiders of Turnstone Biologics Corp.

Location
La Jolla, CA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Turnstone Biologics Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rishi Gupta Director $0 08 Aug 2025
Versant Ventures V, LLC 10%+ Owner $0 08 Aug 2025
Jerel Davis Director $0 08 Aug 2025
ORBIMED ADVISORS LLC Director $0 08 Aug 2025
Kanya Rajangam Director 03 Jun 2024
Saryah Azmat Chief Business Officer 16 Oct 2023
P. Joseph Campisi Jr. Chief Legal Officer 16 Oct 2023
Sammy J. Farah President & CEO, Director 16 Oct 2023
Patrick Machado Director 20 Jul 2023
Stewart Abbot Chief Scientific Officer 16 Oct 2023
Robert J. Gould Director 03 Jun 2024
Venkat Ramanan Chief Financial Officer 16 Oct 2023
Vijay Chiruvolu Int. Chief Technology Officer 20 Jul 2023
FMR LLC Other* 09 Jan 2024
Michael F. Burgess Interim Chief Medical Officer, Director 16 Oct 2023
William D. Waddill Director 03 Jun 2024

Recent Insider Transactions by Companies or Individuals for Turnstone Biologics Corp.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Orbimed Advisors Llc TSBX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -3,099,265 0 08 Aug 2025 See Footnote
Versant Ventures V, LLC TSBX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -274,990 0 08 Aug 2025 By Versant Vantage II, L.P.
Versant Ventures V, LLC TSBX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -82,006 0 08 Aug 2025 By Versant Affiliates Fund V, L.P.
Versant Ventures V, LLC TSBX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -90,888 0 08 Aug 2025 By Versant Ophthalmic Affiliates Fund I, L.P.
Versant Ventures V, LLC TSBX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -207,486 0 08 Aug 2025 By Versant Venture Capital V (Canada) LP
Versant Ventures V, LLC TSBX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -2,726,322 0 08 Aug 2025 By Versant Venture Capital V, L.P.
Jerel Davis TSBX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -82,006 0 08 Aug 2025 By Versant Affiliates Fund V, L.P.
Jerel Davis TSBX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -90,888 0 08 Aug 2025 By Versant Ophthalmic Affiliates Fund I, L.P.
Jerel Davis TSBX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -207,486 0 08 Aug 2025 By Versant Venture Capital V (Canada) LP
Jerel Davis TSBX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -2,726,322 0 08 Aug 2025 By Versant Venture Capital V, L.P.
Jerel Davis TSBX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -274,990 0 08 Aug 2025 By Versant Vantage II, L.P.
Rishi Gupta TSBX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -3,099,265 0 08 Aug 2025 See Footnotes
* An asterisk sign (*) next to the price indicates that the price is likely invalid.